PTO Form 1553 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
77750782 |
LAW OFFICE ASSIGNED |
LAW OFFICE 102 |
EXTENSION OF USE |
NO |
MARK SECTION |
MARK |
YERVOY |
OWNER SECTION (current) |
NAME |
Bristol-Myers Squibb Company |
STREET |
345 Park Avenue |
CITY |
New York |
STATE |
New York |
ZIP/POSTAL CODE |
10154 |
COUNTRY |
United States |
PHONE |
212 546-3064 |
FAX |
212 546-5664 |
OWNER SECTION (proposed) |
NAME |
Bristol-Myers Squibb Company |
STREET |
345 Park Avenue |
CITY |
New York |
STATE |
New York |
ZIP/POSTAL CODE |
10154 |
COUNTRY |
United States |
PHONE |
212 546-3661 |
FAX |
212 546-5664 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system
diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection;
pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies |
GOODS OR SERVICES DELETED FROM THE APPLICATION OR INCLUDED IN A REQUEST TO DIVIDE |
obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, inflammation and
inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals,
anti-virals, immunosuppressants and pharmaceutical antibodies |
GOODS OR SERVICES IN USE IN COMMERCE |
Pharmaceutical preparations for human use for the treatment and prevention of cancer |
FIRST USE ANYWHERE DATE |
03/25/2011 |
FIRST USE IN COMMERCE DATE |
03/25/2011 |
SPECIMEN FILE NAME(S) |
\\TICRS\EXPORT11\IMAGEOUT 11\777\507\77750782\xml5\ SOU0002.JPG |
SPECIMEN DESCRIPTION |
label for the goods |
REQUEST TO DIVIDE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES IN USE |
1 |
SUBTOTAL AMOUNT [ALLEGATION OF USE FEE] |
100 |
TOTAL AMOUNT |
100 |
SIGNATURE SECTION |
DECLARATION SIGNATURE |
/marilyn kelly/ |
SIGNATORY'S NAME |
Marilynn Kelly |
SIGNATORY'S POSITION |
Attorney of record |
DATE SIGNED |
04/29/2011 |
FILING INFORMATION |
SUBMIT DATE |
Fri Apr 29 11:25:18 EDT 2011 |
TEAS STAMP |
USPTO/SOU-XXX.XX.XX.XX-20
110429112518082477-777507
82-4807b2148fe39ed360a4ca
f0dd1912e5c7-DA-12313-201
10429111720447083 |
PTO Form 1553 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: YERVOY
SERIAL NUMBER: 77750782
The applicant, Bristol-Myers Squibb Company, having an address of
345 Park Avenue
New York, New York 10154
United States
is submitting the following allegation of use information:
For International Class 005:
Current identification: Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and
disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical
preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
This
allegation of use does
NOT cover the following goods or services listed in either the application or Notice of Allowance or as subsequently modified for this specific class; these
goods or services are either being
permanently deleted or included in a Request to Divide: obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and
disorders, metabolic disorders, stroke, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical
preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
The mark is in use in commerce on or in connection with the following goods or services listed in either the application or Notice of Allowance or as subsequently modified for this specific class:
Pharmaceutical preparations for human use for the treatment and prevention of cancer
The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 03/25/2011, and first used in commerce at least as early as
03/25/2011, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting
of a(n) label for the goods.
Specimen File1
The applicant is not filing a Request to Divide with this Allegation of Use form.
A fee payment in the amount of $100 will be submitted with the form, representing payment for the allegation of use for 1 class.
Declaration
Applicant requests registration of the above-identified trademark/service mark in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15
U.S.C. Section 1051 et seq., as amended). Applicant is the owner of the mark sought to be registered, and is using the mark in commerce on or in connection with the goods/services identified above,
as evidenced by the attached specimen(s) showing the mark as used in commerce.
The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false
statements may jeopardize the validity of the form or any resulting registration, declares that he/she is properly authorized to execute this form on behalf of the applicant; he/she believes the
applicant to be the owner of the trademark/service mark sought to be registered; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief
are believed to be true.
Signature: /marilyn kelly/ Date Signed: 04/29/2011
Signatory's Name: Marilynn Kelly
Signatory's Position: Attorney of record
RAM Sale Number: 12313
RAM Accounting Date: 04/29/2011
Serial Number: 77750782
Internet Transmission Date: Fri Apr 29 11:25:18 EDT 2011
TEAS Stamp: USPTO/SOU-XXX.XX.XX.XX-20110429112518082
477-77750782-4807b2148fe39ed360a4caf0dd1
912e5c7-DA-12313-20110429111720447083